Citations (48)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (48)
Jiaobo He. (2021) A totally implantable venous access device (TIVAD) abandoned for 5 years is re-accessed normally: A case report and literature review. The Journal of Vascular Access 24:3, pages 502-506.
Crossref
Crossref
Ayhan Erdemir & Huseyin Kemal Rasa. (2023) Impact of central venous port implantation method and access choice on outcomes. World Journal of Clinical Cases 11:1, pages 116-126.
Crossref
Crossref
Yinhuan Wang, Hao Tian, Xianchun Chen, Jiasi Zhang, Li Wang, Haiyan Fan, Yi Zhang, Xiaowei Qi, Shaoyi Hu & Ying Yang. (2022) Safety and feasibility assessment of extending the flushing interval in totally implantable venous access port flushing during the non-treatment stage for patients with breast cancer. Frontiers in Oncology 12.
Crossref
Crossref
Tali Lang, Sarah Jaboury, Alexander West, Jo O'Sullivan, Kirsten Seletto, Lucy Wilson, Elizabeth Gleisner & Gary Richardson. (2022) Is There a Relationship Between Frequency of Port-Care Maintenance and Related Complications in Patients With Cancer?. JCO Oncology Practice 18:9, pages e1438-e1446.
Crossref
Crossref
Melania Cia-Arriaza, Sandra Cabrera-Jaime, Rosario Cano-Soria, Mireia Manzano-Castro, Margarita Domínguez-Gómez, Dolores M. Prieto-Arenas, Angeles Benito-Yagüe, Adela Sánchez-Martín, Cristina González-Alonso & Paz Fernández-Ortega. (2022) Evidence on port-locking with heparin versus saline in patients with cancer not receiving chemotherapy: A randomized clinical trial. Asia-Pacific Journal of Oncology Nursing 9:9, pages 100085.
Crossref
Crossref
Yan Wang, Jian Zhao & Guang-ming Wan. (2022) Prolong the flushing and locking interval of TIVAD is feasible in COVID-19: An overview of systematic reviews. The Journal of Vascular Access, pages 112972982210861.
Crossref
Crossref
Reinhart T. Grundmann. 2022. Port Care. Port Care
103
113
.
Zhao-yu Xiong, Hui-min Zhou & Su-yun Li. (2021) Prolonged flushing and locking interval for totally implantable vascular access device: A systematic review and meta-analysis. The Journal of Vascular Access 22:6, pages 969-978.
Crossref
Crossref
Xiaohong Wu, Tiantian Zhang, Lichan Chen & Xisui Chen. (2020) Prolonging the flush-lock interval of totally implantable venous access ports in patients with cancer: A systematic review and meta-analysis. The Journal of Vascular Access 22:5, pages 814-821.
Crossref
Crossref
Latif Volkan Tumay & Osman Serhat Guner. (2020) Availability of totally implantable venous access devices in cancer patients is high in the long term: a seven-year follow-up study. Supportive Care in Cancer 29:7, pages 3531-3538.
Crossref
Crossref
Marco Clari, Maria Spoto, Giordana Franceschi, Martina Acuto, Simone Tonella, Silvia Caristia, Giulia Buratti, Samanta Gaboardi, Laura Rasero, Sara Campagna, Erica Busca & Alberto Dal Molin. (2021) Short Versus Long Timing of Flushing of Totally Implantable Venous Access Devices When Not Used Routinely. Cancer Nursing 44:3, pages 205-213.
Crossref
Crossref
Sang-Bo Oh, Kwonoh Park, Jae-Joon Kim, So-Yeon Oh, Ki-Sun Jung, Byung-Soo Park, Gyung-Mo Son, Hyun-Sung Kim, Dong-Hyun Kim, Hyuk-Jae Jung & Sang-Su Lee. (2021) Safety and feasibility of 3-month interval access and flushing for maintenance of totally implantable central venous port system in colorectal cancer patients after completion of curative intended treatments. Medicine 100:2, pages e24156.
Crossref
Crossref
Ching-Yang Wu. 2021. Drug Delivery Devices and Therapeutic Systems. Drug Delivery Devices and Therapeutic Systems
91
105
.
Francisca Jane Gomes de Oliveira, Andrea Bezerra Rodrigues, Islane Costa Ramos & Joselany Áfio Caetano. (2020) Dosage of heparin for patency of the totally implanted central venous catheter in cancer patients. Revista Latino-Americana de Enfermagem 28.
Crossref
Crossref
Reinhart T. Grundmann. 2020. Portpflege. Portpflege
115
126
.
Pin-Li Chou, Jui-Ying Fu, Chia-Hui Cheng, Yen Chu, Ching-Feng Wu, Po-Jen Ko, Yun-Hen Liu & Ching-Yang Wu. (2019) Current port maintenance strategies are insufficient. Medicine 98:44, pages e17757.
Crossref
Crossref
Colette Shaw. 2019. Contemporary Pancreas and Small Bowel Transplantation. Contemporary Pancreas and Small Bowel Transplantation
237
262
.
Carla Fornaro, Maria Piubeni, Valeria Tovazzi, Deborah Cosentini, Maria Gelmi, Gabriella Rota, Barbara Berta, Wilma Barucco, Eleonora Lombardi, Luisa Moles, Tiziana Faustini, Tiziana Fettolini, Paolo Motta, Vittorio D. Ferrari, Alfredo Berruti & Elisabetta Conti. (2018) Eight‐week interval in flushing and locking port‐a‐cath in cancer patients: A single‐institution experience and systematic review. European Journal of Cancer Care, pages e12978.
Crossref
Crossref
Shanshan Wu, Wanjiao Li, Qiongxiao Zhang, Shuting Li & Lizi Wang. (2018) Comparison of complications between peripheral arm ports and central chest ports: A meta-analysis. Journal of Advanced Nursing 74:11, pages 2484-2496.
Crossref
Crossref
Laura Rasero, Lisa Golin, Serena Ditta, Dino Stefano Di Massimo, Alberto Dal Molin & Guya Piemonte. (2018) Effects of prolonged flushing interval in totally implantable venous access devices (TIVADs). British Journal of Nursing 27:8, pages S4-S10.
Crossref
Crossref
Hyekyung Kim, Hyunkyung Ku & So-Eun Choi. (2018) A Prospective Study of Extending the Implanted Port Heparin Flushing Cycle in Outpatients with Solid Tumors. Korean Journal of Adult Nursing 30:2, pages 216.
Crossref
Crossref
Colette Shaw. 2018. Contemporary Small Bowel Transplantation. Contemporary Small Bowel Transplantation
1
27
.
Colette M. Shaw, Shrenik Shah, Baljendra S. Kapoor, Thomas R. Cain, Drew M. Caplin, Khashayar Farsad, M-Grace Knuttinen, Margaret H. Lee, Joseph J. McBride, Jeet Minocha, Elizabeth V. Robilotti, Paul J. Rochon, Richard Strax, Elrond Y.L. Teo & Jonathan M. Lorenz. (2017) ACR Appropriateness Criteria ® Radiologic Management of Central Venous Access. Journal of the American College of Radiology 14:11, pages S506-S529.
Crossref
Crossref
Susanne B. Conley, Paula Buckley, Lisa Magarace, Candace Hsieh & Lillian Vitale Pedulla. (2017) Standardizing Best Nursing Practice for Implanted Ports. Journal of Infusion Nursing 40:3, pages 165-174.
Crossref
Crossref
Jorge A. Diaz, Shesh N. Rai, Xiaoyoung Wu, Ju-Hsien Chao, Ajoy L. Dias & Goetz H. Kloecker. (2017) Phase II Trial on Extending the Maintenance Flushing Interval of Implanted Ports. Journal of Oncology Practice 13:1, pages e22-e28.
Crossref
Crossref
J. Fern?ndez-de-Maya & M. Richart-Mart?nez. (2016) Factors associated with variability in management of vascular access ports. European Journal of Cancer Care 25:5, pages 871-882.
Crossref
Crossref
Tae-Seok SeoMyung Gyu SongIn-Ho Cha. (2016) Complications of an Implantable Venous Access Port: Prevention and Treatment. Journal of the Korean Society of Radiology 75:5, pages 333.
Crossref
Crossref
A. Simon. 2016. Ports. Ports
135
147
.
Hye Kyung Kim, So Eun Choi, Jung Hoon Lee, Eun Sook We, Hye Jin Joh & Kwang Sung Kim. (2014) Current Status of Interval of Heparin Flushing for Maintenance of an Implanted Port in Solid Tumor Patients. Journal of Korean Biological Nursing Science 16:3, pages 251-257.
Crossref
Crossref
Hatice Odabas, Nuriye Yıldırım Ozdemir, Ipek Ziraman, Sercan Aksoy, Huseyin Abali, Berna Oksuzoglu, Metin Isik, Burak Civelek, Dogan Dede & Nurullah Zengin. (2013) Effect of port-care frequency on venous port catheter-related complications in cancer patients. International Journal of Clinical Oncology 19:4, pages 761-766.
Crossref
Crossref
. (2014) Evidence-based practice requires research and data. British Journal of Nursing 23:Sup14, pages S3-S3.
Crossref
Crossref
Alberto Dal Molin, Elias Allara, Doriana Montani, Simona Milani, Cristina Frassati, Simonetta Cossu, Simone Tonella, Dania Brioschi & Laura Rasero. (2018) Flushing the Central Venous Catheter: Is Heparin Necessary?. The Journal of Vascular Access 15:4, pages 241-248.
Crossref
Crossref
Nayara N?rley Pires & Christiane Inoc?ncio Vasques. (2014) Nurses' knowledge regarding the handling of the totally-implanted venous access device. Texto & Contexto - Enfermagem 23:2, pages 443-450.
Crossref
Crossref
Alvisa Palese, Debra Baldassar, Alessandro Rupil, Graziella Bonanni, Teresa Capellari Maria, Daniela Contessi, Laura De Crignis, Adriana Vidoni, Sonia Piller Roner & Antonietta Zanini. (2014) Maintaining patency in totally implantable venous access devices (TIVAD): A time-to-event analysis of different lock irrigation intervals. European Journal of Oncology Nursing 18:1, pages 66-71.
Crossref
Crossref
José Fernández-de-Maya & Miguel Richart-Martínez. (2013) Variability in management of implantable ports in oncology outpatients. European Journal of Oncology Nursing 17:6, pages 835-840.
Crossref
Crossref
Eugenia Girda, Rebecca Phaeton, Gary L. Goldberg & Dennis Y. S. Kuo. (2013) Extending the interval for port-a-cath maintenance. Modern Chemotherapy 02:02, pages 15-18.
Crossref
Crossref
Eric M. Walser. (2011) Venous Access Ports: Indications, Implantation Technique, Follow-Up, and Complications. CardioVascular and Interventional Radiology 35:4, pages 751-764.
Crossref
Crossref
Alberto Dal Molin, Dino Stefano Di Massimo, Cesare Braggion, Sofia Bisogni, Elena Rizzi, Ciro D'Orazio, Maria Vittoria Di Toppa, Federico Alghisi, Simona Cristadoro, Vincenzo Carnovale, Gabriella Festa, Serena Rampini, Carla Colombo, Anna Oneta, Maria Lucia Furnari, Maria Antonietta Calamia, Maria Luisa Zunino, Giuseppe Tuccio, Vincenzo Spadea, Barbara Messore, Bianca Grosso & Filippo Festini. (2018) Totally Implantable Central Venous Access Ports in Patients with Cystic Fibrosis: A Multicenter Prospective Cohort Study. The Journal of Vascular Access 13:3, pages 290-295.
Crossref
Crossref
John E. NiederhuberFrancesca Ratti, Marco Catena, Michele Paganelli & Luca Aldrighetti. 2012. Totally Implantable Venous Access Devices. Totally Implantable Venous Access Devices
187
190
.
Alberto Dal Molin, Laura Rasero, Linda Guerretta, Elisa Perfetti & Mario Clerico. (2011) The late complications of totally implantable central venous access ports: The results from an Italian multicenter prospective observation study. European Journal of Oncology Nursing 15:5, pages 377-381.
Crossref
Crossref
Ulf K. Teichgräber, Robert Pfitzmann & Herbert A. F. Hofmann. (2011) Central Venous Port Systems as an Integral Part of Chemotherapy. Deutsches Ärzteblatt international.
Crossref
Crossref
C. HEIBL, V. TROMMET, S. BURGSTALLER, B. MAYRBAEURL, C. BALDINGER, R. KOPLM?LLER, T. K?HR, L. WIMMER & J. THALER. (2010) Complications associated with the use of Port-a-Caths in patients with malignant or haematological disease: a single-centre prospective analysis. European Journal of Cancer Care 19:5, pages 676-681.
Crossref
Crossref
Dawn Camp-Sorrell. (2010) State of the Science of Oncology Vascular Access Devices. Seminars in Oncology Nursing 26:2, pages 80-87.
Crossref
Crossref
Jacquelyn L Baskin, Ching-Hon Pui, Ulrike Reiss, Judith A Wilimas, Monika L Metzger, Raul C Ribeiro & Scott C Howard. (2009) Management of occlusion and thrombosis associated with long-term indwelling central venous catheters. The Lancet 374:9684, pages 159-169.
Crossref
Crossref
A. Dal Molin, L. Guerretta, F. Mazzufero & L. Rasero. (2018) The Management of Totally Implanted Venous Ports in the Ambulatory Oncologic Patient. The Journal of Vascular Access 10:1, pages 22-26.
Crossref
Crossref
F. Cornelius Waller. (2008) Complete Caval Thrombosis Secondary to an Implanted Venous Port – a Case Study: In Reply. Deutsches Ärzteblatt international.
Crossref
Crossref
S. Vescia, A.K. Baumgärtner, V.R. Jacobs, M. Kiechle-Bahat, A. Rody, S. Loibl & N. Harbeck. (2008) Management of venous port systems in oncology: a review of current evidence. Annals of Oncology 19:1, pages 9-15.
Crossref
Crossref
Dawn Camp-Sorrell. (2007) Clinical Dilemmas: Vascular Access Devices. Seminars in Oncology Nursing 23:3, pages 232-239.
Crossref
Crossref